Connect with us

Around The World

Recent Study of COVID-19 Patient Recovery Provides Virus Immunity Response Insight

Published

on

covid

A 47-year-old woman contracted the coronavirus in Wuhan, China before showing symptoms upon her arrival in Melbourne, Australia. A recent study published in the science journal Nature Medicine could provide insights as to why certain people respond differently to the virus. This can lead to possible treatments for upcoming cases. 

Sponsored

 

According to Bloomberg, “Blood samples tested at four different time points showed the 47-year-old woman produced white blood cells that targeted virus-infected cells and spurred the production of antibodies that drove her recovery 10 days after developing a mild-to-moderate illness that required hospitalization.

 

Sponsored

 

 

While she was hospitalized, she did not receive any drug treatments. Instead, she was treated with intravenous fluids to keep her hydrated. Her immune response provides scientists with the opportunity to study why the coronavirus affects people differently which can be helpful in upcoming treatments. 

 

Healthcare professionals also benefit from this information by being more prepared to see which patients might develop more severe symptoms when admitted to the hospitals. Other insights could potentially launch new medical interventions to reduce the severity as well as understand how post-illness immunity works for COVID-19.

 

Sources:

https://www.nature.com/articles/s41591-020-0819-2

https://www.bloomberg.com/news/articles/2020-03-17/covid-19-patient-helps-scientists-map-virus-immune-response

Sponsored

 

Please SHARE this article with your family and friends.

Listen to our NEW Educate Inspire Change Podcast on iTunes HERE

You can follow us on Instagram HERE

You can follow Kash Khan the Creator of EducateInspireChange  @ConsciousKash on Instagram

 

Newsletter

Ads

Support Us

CLICK HERE TO DONATE

Every little bit helps fund the site & keep all the
free information on it. Thanks in advance.

Follow Us :

Ads

Trending